Angle’s Andrew Newland talks to EPM about the high level of interest from across the globe in the company’s cell separation technology, which captures cancer cells circulating in the blood and harvests those cells for analysis
The extent of data breaches in the pharmaceutical sector has been revealed with almost one quarter being hacked and 60% admitting to losing important data
What requirements need to be met by a tablet testing system to guarantee a successful product release? Is it dependable upon the testing system’s quality, speed, technology, flexibility or safety? Kraemer and Ischi explain…
Dr. Paul Clewlow, Sygnature Discovery, talks to EPM about the company’s successful track record in discovering medicines for the benefit of “patients with debilitating diseases such as cancer”
Professor Sam Salek, School of Medical and Life Sciences, University of Hertfordshire, calls for a “universal framework” to speed up the disjointed decision-making process around the commissioning of new drugs
Discussing the potential “doomsday scenario” of a world without antibiotics, Professor Colin Garner, chief executive of Antibiotic Research UK (ANTRUK), says “not all is…bleak” as efforts are being made to remedy the situation
Charlie Cunningham, Colorcon, says continuous coating by far outperforms traditional batch coating and is fast catching on with pharmaceutical customers.
Oliver Wright, solicitor at law firm LHS, says a new high court ruling means improved transparency and a clearer framework for companies operating under regulation by the Health Research Authority
